PERSPECTIVE THERAPEUTICS, INC. Stock Issued During Period, Shares, New Issues
PERSPECTIVE THERAPEUTICS, INC. (CATX) had Stock Issued During Period, Shares, New Issues of 3.38 million shares as of 2025-02-18, per its 10-K filed 2026-03-16.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2026-03-16
- 2025-02-18: Stock Issued During Period, Shares, New Issues 3.38M shares.
- 2021-02-08: Stock Issued During Period, Shares, New Issues 36.00M shares.
- 2020-10-22: Stock Issued During Period, Shares, New Issues 18.27M shares.
- 2012-07-13: Stock Issued During Period, Shares, New Issues 0 month 3.63M shares.
| Period end | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues 0 month |
|---|---|---|
| 2025-02-18 | 3.38M shares 10-K · filed 2026-03-16 | |
| 2021-02-08 | 36.00M shares 10-KT · filed 2023-05-01 | |
| 2020-10-22 | 18.27M shares 10-KT · filed 2023-05-01 | |
| 2012-07-13 | 3.63M shares 10-K · filed 2013-09-30 | |
| 2011-12-07 | 317.99K shares 10-K · filed 2013-09-30 | |
| 2011-10-19 | 2.50M shares 10-K · filed 2013-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |